Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9098691rdf:typepubmed:Citationlld:pubmed
pubmed-article:9098691lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9098691lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9098691lifeskim:mentionsumls-concept:C0389726lld:lifeskim
pubmed-article:9098691lifeskim:mentionsumls-concept:C0035065lld:lifeskim
pubmed-article:9098691lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:9098691lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:9098691lifeskim:mentionsumls-concept:C1140999lld:lifeskim
pubmed-article:9098691pubmed:issue2-3lld:pubmed
pubmed-article:9098691pubmed:dateCreated1997-6-16lld:pubmed
pubmed-article:9098691pubmed:abstractTextTo investigate the alpha 1-adrenoceptor subtype(s) mediating contraction in rat renal artery, we have compared the effect of the alpha 1-adrenoceptor antagonists, 5-methylurapidil, BMY 7378 (8-(2-(4-(2-methoxyphenyl)-1-piperazinyl) ethyl) 8-azaspiro (4.5) decane-7,9-dione 2HCl) and chloroethylclonidine on functional responses to noradrenaline. A clear blockade by chloroethylclonidine (10(-4) M) of noradrenaline-induced contraction was observed and, along with this effect. pKB values of 9.12 and 8.40 for BMY 7378 and 9.75 and 10.06 for 5-methylurapidil were obtained, indicating that the renal artery expresses the alpha 1D-adrenoceptor subtype as the one involved in contraction and not only the alpha 1A subtype as has been reported.lld:pubmed
pubmed-article:9098691pubmed:languageenglld:pubmed
pubmed-article:9098691pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:citationSubsetIMlld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9098691pubmed:statusMEDLINElld:pubmed
pubmed-article:9098691pubmed:monthMarlld:pubmed
pubmed-article:9098691pubmed:issn0014-2999lld:pubmed
pubmed-article:9098691pubmed:authorpubmed-author:Villalobos-Mo...lld:pubmed
pubmed-article:9098691pubmed:authorpubmed-author:IbarraMMlld:pubmed
pubmed-article:9098691pubmed:authorpubmed-author:López-Guerrer...lld:pubmed
pubmed-article:9098691pubmed:issnTypePrintlld:pubmed
pubmed-article:9098691pubmed:day19lld:pubmed
pubmed-article:9098691pubmed:volume322lld:pubmed
pubmed-article:9098691pubmed:ownerNLMlld:pubmed
pubmed-article:9098691pubmed:authorsCompleteYlld:pubmed
pubmed-article:9098691pubmed:pagination225-7lld:pubmed
pubmed-article:9098691pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:meshHeadingpubmed-meshheading:9098691-...lld:pubmed
pubmed-article:9098691pubmed:year1997lld:pubmed
pubmed-article:9098691pubmed:articleTitleAlpha 1D- and alpha 1A-adrenoceptors mediate contraction in rat renal artery.lld:pubmed
pubmed-article:9098691pubmed:affiliationDepartamento de Farmacología y Toxicología, CINVESTAV-IPN, México, D.F., Mexico.lld:pubmed
pubmed-article:9098691pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9098691pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9098691lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9098691lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9098691lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9098691lld:pubmed